LYRA
Lyra Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.32
-0.02 ▼ -1.49%
🌙 3월 13일 5:33 PM ET (한국 3/14 06:33)
$1.32
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -23.78 | Insider Own | 7.93% | Shs Outstand | 0.00B | Perf Week | 3.26% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | -45.74% | Shs Float | 0.00B | Perf Month | -3.65% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 13.67% | Short Float | 1.01% | Perf Quarter | -67.25% |
| Income | -0.03B | P/S | 3.9 | EPS this Y | - | Inst Trans | -58.76% | Short Ratio | 0.21 | Perf Half Y | -79.15% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -53.81% | Short Interest | 0.02M | Perf YTD | -57.14% |
| Book/sh | -2.63 | P/C | 0.11 | EPS past 3/5Y | 24.62% -2.22% | ROE | -404.48% | 52W High | -96.48% ($37.50) | Perf Year | -84.91% |
| Cash/sh | 12.44 | P/FCF | - | Sales past 3/5Y | 75.25% - | ROIC | -147.3% | 52W Low | 45.66% ($0.91) | Perf 3Y | -98.65% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 68.97% | Gross Margin | 3.5% | Volatility(W/M) | 5.75% 12.28% | Perf 5Y | -99.81% |
| Dividend TTM | - | EV/Sales | 19.45 | Sales Y/Y TTM | -59.21% | Oper. Margin | -5401.33% | ATR (14) | 0.16 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.43 | EPS Q/Q | 62.68% | Profit Margin | -5491.17% | RSI (14) | 40.79 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.43 | Sales Q/Q | -87.18% | SMA20 | 0.22% ($1.32) | Beta | -0.08 | Target Price | $7 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -29.54% ($1.87) | Rel Volume | 0.04 | Prev Close | $1.34 |
| Employees | 30 | LT Debt/Eq | - | EPS/Sales Surpr. | 35.68% -87.85% | SMA200 | -77.89% ($5.97) | Avg Volume(3M) | 0.08M | Price | $1.32 |
| IPO | 2020/5/1 | Option/Short | No/Yes | Trades | 55 | Volume | 3,247 | Change | -1.49% |
뉴스 로딩 중...